vs
Side-by-side financial comparison of agilon health, inc. (AGL) and WEIBO Corp (WB). Click either name above to swap in a different company.
agilon health, inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs 0.0%, a 35.7% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs -2.1%).
agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
AGL vs WB — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.3B |
| Net Profit | $49.0K | $458.3M |
| Gross Margin | — | — |
| Operating Margin | — | 29.1% |
| Net Margin | 0.0% | 35.7% |
| Revenue YoY | -3.0% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $841.7M | ||
| Q1 25 | $1.5B | $396.9M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $833.4M |
| Q1 26 | $49.0K | — | ||
| Q4 25 | $-188.9M | — | ||
| Q3 25 | $-110.2M | $458.3M | ||
| Q2 25 | $-104.4M | $234.8M | ||
| Q1 25 | $12.1M | $108.1M | ||
| Q4 24 | $-105.8M | — | ||
| Q3 24 | $-117.6M | $297.4M | ||
| Q2 24 | $-30.7M | $164.6M |
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | — | ||
| Q3 25 | -9.1% | 29.1% | ||
| Q2 25 | -8.3% | 30.4% | ||
| Q1 25 | -1.4% | 27.8% | ||
| Q4 24 | -7.1% | — | ||
| Q3 24 | -9.2% | 29.0% | ||
| Q2 24 | -2.9% | 28.2% |
| Q1 26 | 0.0% | — | ||
| Q4 25 | -12.0% | — | ||
| Q3 25 | -7.7% | 35.7% | ||
| Q2 25 | -7.5% | 27.9% | ||
| Q1 25 | 0.8% | 27.2% | ||
| Q4 24 | -6.9% | — | ||
| Q3 24 | -8.1% | 22.9% | ||
| Q2 24 | -2.1% | 19.8% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.0M | $1.1B |
| Total DebtLower is stronger | $15.3M | — |
| Stockholders' EquityBook value | — | $3.9B |
| Total Assets | $1.5B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $140.0M | — | ||
| Q4 25 | $173.7M | — | ||
| Q3 25 | $171.7M | $1.1B | ||
| Q2 25 | $171.4M | $1.2B | ||
| Q1 25 | $136.9M | $1.2B | ||
| Q4 24 | $188.2M | — | ||
| Q3 24 | $148.2M | — | ||
| Q2 24 | $109.5M | $1.9B |
| Q1 26 | $15.3M | — | ||
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $126.7M | — | ||
| Q3 25 | $306.1M | $3.9B | ||
| Q2 25 | $408.9M | $3.6B | ||
| Q1 25 | $500.3M | $3.5B | ||
| Q4 24 | $471.0M | — | ||
| Q3 24 | $574.9M | — | ||
| Q2 24 | $676.6M | $3.4B |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.6B | $6.9B | ||
| Q2 25 | $1.7B | $6.5B | ||
| Q1 25 | $1.9B | $6.7B | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.2B | $7.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGL
Segment breakdown not available.
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
